Labiotech.eu

News and Trends 26 Feb 2018

AstraZeneca Collaborates With Swedish Biotech To Speed Up Drug Development

AstraZeneca collaborates with Swedish firm Pelago Bioscience to develop assay that increases the speed and efficiency of drug development. Pelago, a Karolinska Institute spin-off, studies the interactions between a drug and its target to make the drug development process faster and more efficient. The Cellular Thermal Shift Assay (CETSA) was developed by Pelago to examine the […]

February 26, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 26 Feb 2018

ASIT Biotech Raises €13.9 M to Develop Allergy Immunotherapies

ASIT Biotech, a Belgian company specialized in allergy immunotherapy, raised a total of €13.9M to develop immunotherapies against against grass pollen, peanut and house dust mite allergies. After raising €9.4M in January, ASIT Biotech has now brought the amount raised on the Euronext Brussels stock up to €13.9M. The funds will be put towards the Phase III […]

February 26, 2018 - 3 minutesmins - By Alexander Burik

multiple sclerosis antibody CIDP geneuro 1

News and Trends 26 Feb 2018

This Multiple Sclerosis Drug Could Help to Fight Another Autoimmune Disease

The FDA has awarded Orphan Drug Designation to GeNeuro’s antibody for the treatment of a rare autoimmune disease following promising Phase IIb results in multiple sclerosis patients. GeNeuro develops therapies targeting factors encoded by human endogenous retroviruses that are implicated in neurological and autoimmune disorders. The biotech’s drug, GNbAC1, which is being developed for multiple […]

February 26, 2018 - 2 minutesmins - By Alex Dale

News and Trends 26 Feb 2018

This Oral Vaccine for Typhoid Raises €8M from International Investors

Prokarium has raised $10M (€8M) from Saudi, Swedish and Korean investors to support the clinical development of its oral vaccines for infectious diseases like typhoid. Since its foundation in 2012, Prokarium has been working on oral vaccines and it has developed a delivery platform that can be applied to any antigen used for vaccination. The biotech has […]

February 26, 2018 - 3 minutesmins - By Alex Dale

Interview 26 Feb 2018

This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis

The use of opioids and non-steroidal anti-inflammatory drugs (NSAIDs) is a massive public health issue. I spoke with Simon Westbrook, CEO of Levicept, whose new approach to pain relief, which is being tested for osteoarthritis, could be a game-changer. Back in September, a couple of weeks into my time at Labiotech, I got the chance […]

February 26, 2018 - 9 minutesmins - By Alex Dale

More News! 24 Feb 2018

The First and Only Museum of Microbes Captivates Amsterdam

Micropia, a museum of microbes located in the heart of Amsterdam, uses art to address the big knowledge gap between science and the general public. Microbiology originated just a few kilometers from Amsterdam when Antoni van Leeuwenhoek built one of the first microscopes and discovered that everyday objects, as well as himself, were teeming with minuscule forms of life. More […]

February 24, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Feb 2018

Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes

Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a GLP-1 based treatment for type II diabetes. This could be the first oral GLP-1 treatment on the market, making it easier for patients to take the drug. After obtaining approval for an injected version, Novo Nordisk is now getting ready […]

February 23, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 23 Feb 2018

Crack Open the Champagne, AiCuris’ Antiviral Launched in Germany

Update (23/02/2018): Merck Sharp & Dohme (MSD), licensee of AiCuris, has launched letermovir in Germany under the trade name Prevymis. The antiviral drug will be available to patients undergoing a hematopoietic stem cell transplant (HSCT) to prevent reactivation of latent human cytomegalovirus (CMV), which can prove lethal in the weakened state of this patients. Update (31/01/2018): […]

February 23, 2018 - 3 minutesmins - By Alex Dale

News and Trends 22 Feb 2018

GW Pharma’s Latest Cannabinoid Drug Pegged Back by a Placebo in Phase II

One of GW Pharma’s cannabinoid drugs for epilepsy has suffered a set back in a Phase IIa trial as a placebo matched its capacity to reduce the frequency of focal seizures. GW Pharma wants to use cannabinoid drugs to treat conditions like autism and epilepsy. However, one of its drug candidates, GWP42006, has slipped up in a Phase […]

February 22, 2018 - 2 minutesmins - By Alex Dale

News and Trends 22 Feb 2018

Bacteria-Killing Viruses Could Stop You From Getting Food Poisoning

A group of Finnish scientists has demonstrated that phage could be used to prevent food poisoning by killing dangerous foodborne pathogens like Yersinia enterocolitica. Researchers at the University of Helsinki believe that bacteria-killing viruses called phage could be more than just an alternative to antibiotics and a solution to the growing antibiotic resistance crisis. A study, published […]

February 22, 2018 - 3 minutesmins - By Alex Dale

News and Trends 22 Feb 2018

You Will Soon Be Able To Paint With Bacteria!

Researchers in the UK and the Netherlands have unlocked the genetic code that changes the color of certain bacteria. The discovery could lead to large-scale manufacturing of biodegradable, non-toxic paint. In a collaborative study between the University of Cambridge and the Dutch company Hoekmine, researchers compared the genetic information of certain bacterial colonies to their […]

February 22, 2018 - 3 minutesmins - By Alexander Burik

hiv treatment immunologik christian setz 1

Interview 22 Feb 2018

Could a New Approach Help Us to Overcome Resistance to HIV Treatment?

Clara chatted with Christian Setz, CEO of Immunologik, to find out how the company is developing a new HIV treatment that could overcome resistance to anti-retroviral drugs. Over 36 million people are living with human immunodeficiency virus (HIV), which has led to many biotechs, including Abivax, working on better options for patients. Immunologik, a recent ‘Biotech of the Week’, is […]

February 22, 2018 - 4 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

AstraZeneca Collaborates With Swedish Biotech To Speed Up Drug Development

ASIT Biotech Raises €13.9 M to Develop Allergy Immunotherapies

This Multiple Sclerosis Drug Could Help to Fight Another Autoimmune Disease

This Oral Vaccine for Typhoid Raises €8M from International Investors

This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis

The First and Only Museum of Microbes Captivates Amsterdam

Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes

Crack Open the Champagne, AiCuris’ Antiviral Launched in Germany

GW Pharma’s Latest Cannabinoid Drug Pegged Back by a Placebo in Phase II

Bacteria-Killing Viruses Could Stop You From Getting Food Poisoning

You Will Soon Be Able To Paint With Bacteria!

Could a New Approach Help Us to Overcome Resistance to HIV Treatment?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!